Automating SEO and Link Building for AI Agents with Rapid Indexer's New MCP Server1
GlobeNewswire
Today at 11:06am UTC
Unfair Links Launches a Link Building Service for Local Backlinks and Google Business Profile Matched Links
GlobeNewswire
Today at 11:02am UTC
Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO
PR Newswire
Today at 11:01am UTC
NovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development
GlobeNewswire
Today at 11:00am UTC
Beyond GRC: DigitalXForce Pioneers AI-Powered Risk Operations with Global X-ROC™ Rollout
PR Newswire
Today at 11:00am UTC
KBB Trade-In Advisor Now Live at Orrville Chevrolet
Press Services
Today at 10:45am UTC
The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and...
PR Newswire
Today at 10:37am UTC
Springs Rejuvenation Clarifies Exosome Therapy Status Across 5 US Clinics
Press Services
Today at 10:30am UTC
Springs Rejuvenation Explains What a Hair Loss Evaluation Covers
Press Services
Today at 10:30am UTC
Best AI Tools for Small Business Marketing (2026): CapCut Featured for Creating Professional Video and Visual Content by Expert Consumers
PR Newswire
Today at 10:30am UTC
Beyond Live Streaming: Tango Gives Back by Supporting Cancer Detection in Ukraine
GlobeNewswire
Today at 10:26am UTC
SI vs. AI: Super Intelligence Anomaly Outbreaks Trump’d by Clinton Legacy Tech (Veterans First for America)
GlobeNewswire
Today at 10:22am UTC
Borr Drilling Limited - Prospector 5 Rig Incident
PR Newswire
Today at 10:22am UTC
Best Broadband Provider for Small Businesses UK (2026): Love Business Group Recognised for Helping SMEs Compare Business Broadband Options...
PR Newswire
Today at 10:00am UTC
Best Protective iPhone Cases for 2026: Top Slim and Drop-Protection Options for iPhone 18 Pro & iPhone 18 Pro Max Recommended by...
PR Newswire
Today at 9:30am UTC
GHK-Cu Copper Peptide 50mg Ships Across Canada with COA
Press Services
Today at 9:15am UTC
Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High...
GlobeNewswire
Today at 9:15am UTC
New data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell...
PR Newswire
Today at 7:30am UTC
BioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy...
GlobeNewswire
Today at 7:30am UTC
Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule
PR Newswire
Today at 7:30am UTC